Latest filing published 06 Jul 2026 for Rocket Pharmaceuticals, INC.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Roderick Wong is a declared insider at 2 companies (board member); the most frequent names are Rocket Pharmaceuticals, Inc. and Orchestra BioMed Holdings, Inc. In total, 5 filings cover trades dated from 27 August 2021 to 18 June 2026.
On the market, this insider has only ever bought: 2 purchases. No amount is published for 2 filings, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 3 share grants.
Most recently, on 6 July 2026, the filings show a share grant in Rocket Pharmaceuticals, Inc. The last insider purchase was made public on 26 January 2023, 1,361 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations